Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 4107-4110

  Hernández Hernández, Francisca ^a,b,c,d   Fréalle, Emilie ^a,b,c   Caneiro, Patrick ^a,b,c   Salleron, Julia ^c   Durand Joly, Isabelle ^c,e   Accoceberry, Isabelle ^f   Bouchara, Jean Philippe ^g,h   Wallaert, Benoit ^c   Dei Cas, Eduardo ^a,b,c   Delhaes, Laurence ^a,b,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM U1019   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e Hospital of Dunkirk   (France)

^f HÔPITAL SAINT ANDRÉ   (France)

^g ANGERS UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DEOXYRIBONUCLEASE; FUNGAL DNA; METICILLIN; STEROID;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DNA EXTRACTION; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; FORCED EXPIRATORY VOLUME; FRANCE; FUNGAL COLONIZATION; FUNGUS IDENTIFICATION; GENOTYPE; GEOGRAPHICAL VARIATION (SPECIES); HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; SCEDOSPORIUM APIOSPERMUM; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; CARRIER STATE; CYSTIC FIBROSIS; FEMALE; FRANCE; GENOTYPE; HUMANS; MALE; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECII; PROSPECTIVE STUDIES; YOUNG ADULT;

PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII; PSEUDOMONAS AERUGINOSA;

EID: 84869215252     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01974-12     Document Type: Article

References (32)

1. Beard CB, et al. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6:265-272. (Pubitemid 30396382)
2. Blyth CC, et al. 2010. Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med. Mycol. 48(Suppl 1):S37-S44.
3. Borman AM, et al. 2010. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med. Mycol. 48 (Suppl 1):S88-S97.
4. Botterel F, et al. 2012. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J. Clin. Microbiol. 50:227-231.
5. Calderón EJ, Friaza V, Dapena FJ, de La Horra C. 2010. Pneumocystis jirovecii and cystic fibrosis. Med. Mycol. 48 (Suppl 1):S17-S21.
6. Calderón EJ, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E. 2010. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev. Anti Infect. Ther. 8:683-701.
7. Calderón EJ, et al. 2007. Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jirovecii. Clin. Infect. Dis. 45:e17-e19.
8. Delhaes L, et al. 2012. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implication for therapeutic management. PLoS One. 7:e36313. doi:10.1371/journal.pone.0036313.
9. Döring G, Parameswaran IG, Murphy TF. 2011. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol. Rev. 35:124-146.
10. Esteves F, et al. 2012. Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies. Clin. Microbiol. Infect. 18:E177-E184.
11. Guss AM, et al. 2011. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 5:20-29.
12. Gutiérrez S, et al. 2011. Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite 18:121-126.
13. Larsen HH, et al. 2002. Development and evaluation of a quantitative, touchdown, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J. Clin. Microbiol. 40:490-494. (Pubitemid 34130872)
14. Le Gal S, et al. 2010. Pneumocystis jirovecii and cystic fibrosis in France. Scand. J. Infect. Dis. 42:225-227.
15. Lu Y, et al. 2011. PCR diagnosis of Pneumocystis pneumonia: a bivariate meta-analysis. J. Clin. Microbiol. 49:4361-4363.
16. Miller RF, Evans HE, Copas AJ, Cassell JA. 2007. Climate and genotypes of Pneumocystis jirovecii. Clin. Microbiol. Infect. 13:445-448. (Pubitemid 46390236)
17. Miller RF, et al. 2005. Genotypic variation in Pneumocystis jirovecii isolates in Britain. Thorax 60:679-682. (Pubitemid 41129067)
18. Montes-Cano MA, et al. 2007. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients. Clin. Microbiol. Infect. 13:1008-1011. (Pubitemid 47382257)
19. Montes-Cano MA, et al. 2004. Pneumocystis jirovecii genotypes in the Spanish population. Clin. Infect. Dis. 39:123-128. (Pubitemid 38879559)
20. Montes-Cano MA, et al. 2006. Polymorphisms in Pneumocystis jirovecii strains in Spanish children with cystic fibrosis. J. Infect. Dis. 193:1332-1333.
21. Morris A, Norris KA. 2012. Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 25:297-317.
22. Pederiva MA, et al. 2012. High prevalence of Pneumocystis jirovecii colonization in Brazilian cystic fibrosis patients. Med. Mycol. 50:556-560.
23. Quattrucci S, et al. 2005. Lung transplantation for cystic fibrosis: 6-year follow-up. J. Cyst. Fibros. 4:107-114. (Pubitemid 40867760)
24. Respaldiza N, et al. 2005. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain. Clin. Microbiol. Infect. 11:1012-1015. (Pubitemid 41748936)
25. Royce FH, Blumberg DA. 2000. Pneumocystis carinii isolated from lung lavage fluid in an infant with cystic fibrosis. Pediatr. Pulmonol. 29:235-238. (Pubitemid 30141801)
26. Sing A, Geiger MA, Hogardt M, Heesemann J. 2001. Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR. J. Clin. Microbiol. 39:2717-2718. (Pubitemid 32606268)
27. Sivam S, et al. 2011. Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients. Diagn. Microbiol. Infect. Dis. 71:24-248.
28. Totet A, et al. 2004. Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology 150:1173-1178. (Pubitemid 38744717)
29. Totet A, et al. 2004. Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg. Infect. Dis. 10:667-673. (Pubitemid 38420298)
30. Ulrich M, et al. 2010. Alveolar inflammation in cystic fibrosis. J. Cyst. Fibros. 9:217-227.
31. van der Gast CJ, et al. 2011. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J. 5:780-791.
32. Visconti E, et al. 2000. Very low frequence of Pneumocystis carinii DNA detection by PCR in specimens from patients with lung damage. J. Clin. Microbiol. 38:1307-1308. (Pubitemid 30140613)